OPENING REMARKS BY GIRP PRESIDENT 
Katarina Gabrielson, GIRP President and CEO, Oriola

KEYNOTE AND Q&A
Christina Egelund, Acting Danish Minister for Higher Education and Science and Member of Parliament

9:05-9:35

KEYNOTE – The Future of European Health Systems 
Bogi Eliasen, Executive Director, Movement Health Foundation

PANEL – Future Foresight: How Will Europe Look Like in 2040?

Moderator: Kasper Ernest, Director General, GIRP

• Bogi Eliasen, Executive Director, Movement Health Foundation 
• Kai Kaasalainen, Director-General, Tamro and Member, World Economic Forum Specialist Group
• Markus Kalliola, Programme Director, International Programmes, Sitra

COFFEE BREAK 

FIRESIDE CHAT – AI: What’s Coming Next?

• Dr Kanwar Preet Singh Sandhu, Global Head of Strategic Initiatives, Cyber Security, Tata Consulting
• Kasper Ernest, Director-General, GIRP 

PANEL – AI in Practice: How Can AI Improve Productivity?  

Moderator: Kasper Ernest, Director-General, GIRP

• Dr Kanwar Preet Singh Sandhu, Global Head of Strategic Initiatives, Cyber Security, Tata Consulting
• Dr Klaus Dohrmann, Vice President, Global Head of Innovation & Trend Research, DHL
• Andreas Koch, Chief Wholesale & Logistics, Galenica
• Matthias Dalkner, Vice President, Healthcare Solutions, KNAPP

LUNCH 

PRESENTATION – GIRP Sector Study on Pharmaceutical Systemic Wholesalers
Fatima Wafqui, Research Associate, Medical Technology Research Group, London School of Economics

PANEL – A World Without Systemic Wholesalers: What if Public Service Providers Were No More?  

Introduction by Irena Toneva, Director, Supplier Services, IQVIA
Moderator: Kasper Ernest, Director-General, GIRP 

• Maja Leon Grzymkowska, Legal Officer, Medical Products: Quality, Safety, Innovation, DG SANTE
• Ancel·la Santos Quintano, Head of Food, Health, and Chemicals Safety, BEUC (The European Consumer Organisation)
• Valeria Ronzitti, General Secretary, SGI Europe
• Alain Roudergues, Director-General, SECOF
• Fatima Wafqui, Research Associate, Medical Technology Research Group, London School of Economics 

PRESENTATION – Outlook on Shifts in the US Pharmaceutical Market  
Heather Meade, Principal, EY/Washington Council Ernst & Young

CLOSING REMARKS OF DAY 1
Kasper Ernest, Director-General, GIRP 

KEYNOTE – Advancing Equitable Access to Medicines in Europe: WHO Perspective 
Rasmus P. Gjesing, Regional Adviser, Access to Medicines & Health Products, WHO Europe

PRESENTATION – The Changing Shape of Healthcare Markets
Simon Tottman, Vice President, Global Strategic Partners, IQVIA
Max Newton, Principal, Global Strategic Partners, IQVIA 

PANEL – The Future of Pharmaceutical Distribution: New Practices, New Actors, New Challenges 

Moderator: Eddy Gilissen, Senior Director, Supplier Alliance, IQVIA 

• Bo Kristensen Jessen, Head of Strategic Account, Europe and Canada, Novo Nordisk
• Albert Hofbauer, Head of Operations Logistics, Managing Director of Pharmaceutical Transport, Kwizda  
• Matthias Heck, Senior Advisor Strategic Alliance Development, EUCOPE
• Pascal Bekaert, Head of Global Trade Effectiveness & Channels Strategy, Sanofi

10:00-11:00

COFFEE BREAK 

PANEL – The Role of Preventive Care in a Shifting Health Architecture

Introduction by Kelsey Stoddart, Senior Consultant, IQVIA
Moderator: Kasper Ernest, Director-General GIRP 

• Antoine Pivron, Vice President, Health Solutions, Withings
• Prof Magnus T. Jensen, Chief Executive Officer, Steno Diabetes Center Copenhagen
• Tom Murray, Former President, Irish Pharmacy Union
• António Valério Rosa, Manufacturer Commercial Director, Member of the Executive Committee, Empifarma

CLOSING REMARKS 
Kasper Ernest, Director-General, GIRP